EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Renal Concerns in the Treatment of Chronic Hepatitis B with Tenofovir

Giuseppe Coppolino, Valeria Cernaro, Laura Rivoli, Angela Pinciaroli, Davide Bolignano

Journal of Renal and Hepatic Disorders · 2017

DOI: 10.15586/jrenhep.2017.11 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Renal and Hepatic Disorders, 2017. Verfasst von Giuseppe Coppolino und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tenofovir, a third generation oral nucleos(t)ide analogue, currently represents one of the first-line drugs recommended for treating chronic hepatitis B virus (HBV) infection. After oral administration, tenofovir is mostly excreted in the urine by glomerular filtration and proximal tubular secretion. Hence, an impaired kidney function may lead to an increased renal exposure to the drug in patients with coexistent renal damage. This could further worsen kidney disease through different mechanisms of nephrotoxicity such as mitochondrial DNA depletion and tubular cytotoxicity. Despite several studies performed so far to assess tenofovir-related renal toxicity, data in HBV patients are not yet conclusive. Screening of risk factors for kidney disease before starting therapy and a careful monitoring of serum creatinine, glomerular filtration rate, serum phosphate and urine analysis during treatment are advocated to adjust the dose or stop treatment if needed. New biomarkers of tubular injury, such as neutrophil gelatinase associated lipocalin, could become helpful in the future for the timely identification and risk stratification of renal damage induced by tenofovir.

Zitieren

APA

Coppolino, G., Cernaro, V., Rivoli, L., Pinciaroli, A., & Bolignano, D. (2017). Renal Concerns in the Treatment of Chronic Hepatitis B with Tenofovir. Journal of Renal and Hepatic Disorders. https://doi.org/10.15586/jrenhep.2017.11

Vancouver

Coppolino G, Cernaro V, Rivoli L, Pinciaroli A, Bolignano D. Renal Concerns in the Treatment of Chronic Hepatitis B with Tenofovir. Journal of Renal and Hepatic Disorders. 2017. doi:10.15586/jrenhep.2017.11

BibTeX
@article{Coppolino2017,
  author = {Coppolino, Giuseppe and Cernaro, Valeria and Rivoli, Laura and Pinciaroli, Angela and Bolignano, Davide},
  title = {Renal Concerns in the Treatment of Chronic Hepatitis B with Tenofovir},
  journal = {Journal of Renal and Hepatic Disorders},
  year = {2017},
  doi = {10.15586/jrenhep.2017.11}
}
Kostenlos starten →